Home » Business » Hyundai Pharmaceutical Recalls High Blood Pressure and Dementia Medication in Containers: Product Safety Investigation

Hyundai Pharmaceutical Recalls High Blood Pressure and Dementia Medication in Containers: Product Safety Investigation

Hyundai Pharmaceutical distributes dementia medicine in containers for high blood pressure treatment

Hyundai Pharmaceutical started collecting the high blood pressure treatment ‘Hyundai Minoxidil Tab’ and the dementia treatment ‘Tamirin Tab’ in distribution.

According to the Ministry of Food and Drug Safety, Hyundai Pharm is voluntarily recalling product number 23018, which has a manufacturing date of May 15, 2023 and an expiry date of May 14, 2026, among 30 Hyundai Minoxidil tablets.

A total of 19,900 bottles are known to be recalled.

The Ministry of Food and Drug Safety announced this on the Internet homepage of ‘Drug Safety Nara’ and announced that it was investigating how the product was entered incorrectly and whether consumers were taking it.

Reporter Seo Hyeong-seok (codealpha@yna.co.kr)

#minoxidil #hair loss drug #tamerin

Yonhap News TV article inquiries and reports: Kakao Talk/Line jebo23

(end)

2023-07-01 10:01:19
#Hyundai #Pharmaceutical #distributes #dementia #medicine #containers #high #blood #pressure #treatment

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.